Estimation of creatinine clearance in morbidly obese patients

被引:122
作者
Demirovic, Jasmina A. [2 ]
Pai, Amy Barton [2 ,3 ]
Pai, Manjunath P. [1 ,2 ]
机构
[1] Ordway Res Inst, Inst Clin Pharmacodynam, Latham, NY 12186 USA
[2] Univ New Mexico, Coll Pharm, Albuquerque, NM 87131 USA
[3] Albany Coll Pharm & Hlth Sci, Dept Pharm Practice, Albany, NY USA
关键词
Calculations; Creatinine; Methodology; Obesity; Weight; RENAL-FUNCTION; UNITED-STATES; BODY-MASS; PREDICTION; DESCRIPTOR; EQUATIONS; SERUM;
D O I
10.2146/ajhp080200
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Purpose. Estimates of creatinine clearance (CL) based on equations and various body-size descriptors were compared with 24-hour measured CLcr values in morbidly obese patients. Methods. Patients age 18-75 years with a body mass index (BMI) of >= 40 kg/m(2) with stable serum creatinine values were enrolled. Covariates known to contribute to alteration in CLcr were used to exclude patients. Twenty-four-hour urine collection was performed to measure CLcr Bioelectric impedance analysis was used to estimate fat-free weight (FFW). Glomerular filtration rate was estimated using the four-variable Modification of Diet in Renal Disease (MDRD4) equation. CLcr was estimated using the Cockcroft-Gault and Salazar-Corcoran methods using total body weight (TBW). Body-size descriptors, such as ideal body weight (IBW), adjusted body weight (ABW), and lean body weight (LBW), and FFW were substituted in the Cockcroft-Gault equation to generate additional estimates of Cl-cr. Results. Fifty-four patients (mean +/- S.D. age, 48.4 +/- 12.9 years; TBW, 142.3 +/- 41.7 kg; BMI, 50.5 +/- 12.6 kg/m(2)) completed the study. All three equations were biased in their estimation of CLcr. Use of MDRD4 and IBW in the Cockcroft-Gault equation underestimated CLcr, while the Salazar-Corcoran equation and use of TBW or ABW in the Cockcroft-Gault equation overestimated this value. Substitution of fat-free weight or LBW in the Cockcroft-Gault equation provided unbiased estimates of CLcr. Conclusion. An LBW estimate, based on TBW and BMI, incorporated into the Cockcroft-Gault equation provided an unbiased, relatively precise, accurate, and clinically practical estimate of 24-hour measured CLcr in morbidly obese patients.
引用
收藏
页码:642 / 648
页数:7
相关论文
共 24 条
[1]  
*AM SOC CLIN NUTR, 1996, AM J CLIN NUTR S, V64, pS524
[2]  
[Anonymous], K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification
[3]   Glomerular hemodynamics in severe obesity [J].
Chagnac, A ;
Weinstein, T ;
Korzets, A ;
Ramadan, E ;
Hirsch, J ;
Gafter, U .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2000, 278 (05) :F817-F822
[4]   PREDICTION OF CREATININE CLEARANCE FROM SERUM CREATININE [J].
COCKCROFT, DW ;
GAULT, MH .
NEPHRON, 1976, 16 (01) :31-41
[5]   ESTIMATING CREATININE CLEARANCE IN MORBIDLY OBESE PATIENTS [J].
DIONNE, RE ;
BAUER, LA ;
GIBSON, GA ;
GRIFFEN, WO ;
BLOUIN, RA .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1981, 38 (06) :841-844
[6]   A standard weight descriptor for dose adjustment in the obese patient [J].
Duffull, SB ;
Dooley, MJ ;
Green, B ;
Poole, SG ;
Kirkpatrick, CMJ .
CLINICAL PHARMACOKINETICS, 2004, 43 (15) :1167-1178
[7]   Obesity, diabetes, and chronic kidney disease [J].
Eknoyan G. .
Current Diabetes Reports, 2007, 7 (6) :449-453
[8]   EFFECT OF OBESITY ON BIOELECTRICAL IMPEDANCE [J].
GRAY, DS ;
BRAY, GA ;
GEMAYEL, N ;
KAPLAN, K .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1989, 50 (02) :255-260
[9]   What is the best size descriptor to use for pharmacokinetic studies in the obese? [J].
Green, B ;
Duffull, SB .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 58 (02) :119-133
[10]   Dosing in obesity: A simple solution to a big problem [J].
Han, P. Y. ;
Duffull, S. B. ;
Kirkpatrick, C. M. J. ;
Green, B. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 82 (05) :505-508